Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Pharma ADMET Testing Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for pharma admet testing has seen a swift expansion in the past few years. An anticipated growth from $9.67 billion in 2024 to $10.7 billion in 2025 denotes a compound annual growth rate (CAGR) of 10.6%. Factors that contributed to the market growth in the historical period include increasing drug development activities, enhancing awareness about drug safety, escalating biopharmaceuticals and biosimilars, expanding clinical trial globalization and a shift towards in silico modeling.

Rapid expansion is anticipated for the pharma admet testing market size in the forthcoming years, with projections indicating it will escalate to $17.03 billion by 2029, posting a compound annual growth rate (CAGR) of 12.3%. This growth during the projected period can be credited to various factors such as environmental toxicology, safety assessment, cognizance towards pharmacogenomics, emphasis on precision medicine, ascendancy of biologics and biosimilars, incorporation of artificial intelligence (AI), broadened regulatory stipulations, and the surge in orphan drug development. Notable trend shifts expected during this period encompass an increase in research collaborations, speedy advances in technology, analytical technology enhancements, unceasing surveillance of drug safety, and considerations of environmental impact.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Pharma ADMET Testing Market?

The increase in the number of product approvals is fuelling the growth of the pharma ADMET testing market. The term ‘product approvals’ refers to the authorization process undertaken by regulatory bodies such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) in Europe, which allows a product to be sold and promoted to consumers. ADMET testing, which is requisite for product regulatory approvals, is instrumental in evaluating the safety and effectiveness of new products. For example, the National Library of Medicine, a US-based biomedical library and health professional resource, reported that there were 55 new FDA-approved drugs in January 2024, an increase from the 37 drugs that were approved in 2022. Consequently, the escalating trend in product approvals is propelling the pharma ADMET testing market.

Which Key Market Segments Comprise the Pharma ADMET Testing Market and Drive Its Revenue Growth?

The pharma admet testingmarket covered in this report is segmented –

1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing

2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology

3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

Subsegments:

1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies

2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing

3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

Which Areas Are Leading Regions in the Pharma ADMET Testing Market Expansion Across the Globe?

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering thePharma ADMET Testing Market Direction?

A significant trend emerging in the pharma ADMET testing market is product innovation. Leading companies in this market, are launching ground-breaking products such as Logica to retain their market dominance. In April 2022, for example, Charles River Laboratories International Inc, a pharmaceutical firm based in the US, and Valo Health Inc, a provider of AI-health solutions also based in the US, introduced Logica, a solution for AI-driven drug development. This new solution utilizes Valo’s AI-enabled Opal Computational Platform to offer ADMET testing services along with other drug delivery solutions. Logica employs premier predictive models, chemical design and synthesis capabilities, DNA encoded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. This, combined with Charles River’s unparalleled expertise in all facets of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission, renders it particularly effective.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

How Is the Pharma ADMET Testing Market Conceptually Defined?

Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model